Mountain Group Capital

PinkDx is a biotechnology company.

Airvet Inc. is a veterinary telemedicine platform that connects pet owners with veterinarians through a user-friendly application. Founded in 2018 and based in Beverly Hills, California, Airvet enables pet parents to schedule virtual appointments for general health checkups, medical inquiries, and behavioral concerns via live video, audio, and chat. This innovative approach fosters ongoing relationships between veterinarians and clients, enhancing the continuity of care that was previously difficult to maintain. By providing affordable access to veterinary services, Airvet aims to improve the health and well-being of pets, while also driving clinic revenue and integrating veterinarians into a modern veterinary community.

Vytelle, LLC is a biotechnology company based in Hermiston, Oregon, focused on enhancing livestock genetics for beef and dairy producers. Founded in 2015 and originally named Cogent IVF, Vytelle specializes in ovum pick-up and embryo production services, which include implantation and post-in vitro fertilization consultation. The company utilizes an integrated technology platform that employs reproductive technology and a proprietary culture system free from fetal calf serum. This innovative approach produces freezable embryos, allowing commercial producers to achieve sustainable genetic gains across generations. Vytelle aims to reshape the cattle industry by optimizing herd performance through advanced reproductive techniques.

Silicon Ranch Corporation is a developer, owner, and operator of utility-scale solar power projects, headquartered in Nashville, Tennessee. Founded in 2010, the company focuses on creating cost-effective solar energy solutions for a diverse range of clients, including utilities, military facilities, and various industrial and commercial businesses. Silicon Ranch is committed to long-term ownership of its projects, ensuring ongoing support and performance accountability to its partners and the communities it serves. In addition to its solar installations, which include facilities in Georgia and Tennessee, the company also operates a regional energy-training center that provides training in solar installation, maintenance, and weatherization. This comprehensive approach not only promotes the adoption of renewable energy but also contributes to local economic development and job creation.

AngelEye Health offers a tele-engagement platform that facilitates the integration of parents into their child's care team during neonatal intensive care or pediatric stays. This HIPAA-compliant platform provides families with access to vital information about their child's treatment plan and progress through bedside cameras, patient communication tools, feeding management, and educational resources. By enhancing communication and involvement, AngelEye Health aims to improve family experiences, care delivery workflows, and patient outcomes, ultimately supporting a successful transition home. The platform is designed to be accessible from any connected device, allowing families to stay informed and engaged throughout their child's care journey.

Verility is focused on enhancing reproductive performance in livestock to meet the growing demand for meat protein and improve food sustainability. The company develops veterinary medical devices that provide accurate and cost-effective analysis of animal semen samples at the point of care, along with ovulation prediction. Utilizing advanced image recognition and artificial intelligence, Verility's products enable animal-side sperm quality assessments and rapid evaluation of cell morphology. This technology assists livestock producers and breeders in determining the optimal timing for breeding, thereby improving overall efficiency in animal reproduction.

TARGAN is a bio-systems company dedicated to enhancing animal health and productivity in the poultry, livestock, and aquaculture sectors. It is developing an innovative vaccination system that aims to replace traditional mass spray methods with a more precise approach, ensuring that every newly hatched chick receives the appropriate vaccine. This technology not only aims to improve immunization rates but also enhances the natural immune response to diseases, leading to better overall flock health. By increasing vaccination accuracy and consistency, TARGAN's solution helps reduce reliance on antibiotics, contributing to cleaner and healthier livestock. The company's focus on improving animal well-being and operational efficiency positions it as a leader in the field of animal production.

Silicon Ranch Corporation is a developer, owner, and operator of utility-scale solar power projects, headquartered in Nashville, Tennessee. Founded in 2010, the company focuses on creating cost-effective solar energy solutions for a diverse range of clients, including utilities, military facilities, and various industrial and commercial businesses. Silicon Ranch is committed to long-term ownership of its projects, ensuring ongoing support and performance accountability to its partners and the communities it serves. In addition to its solar installations, which include facilities in Georgia and Tennessee, the company also operates a regional energy-training center that provides training in solar installation, maintenance, and weatherization. This comprehensive approach not only promotes the adoption of renewable energy but also contributes to local economic development and job creation.

Circular Genomics is a company based in Albuquerque, New Mexico, specializing in the development of circular RNA diagnostics to enhance precision medicine in the treatment of neurological and psychiatric conditions. Founded in 2021, the company aims to improve the diagnosis and treatment of depressive disorders by utilizing circular RNA as a novel biomarker. This innovative approach allows for evidence-based treatment strategies, significantly reducing the time required for patients to achieve a therapeutic response. By focusing on the potential of circular RNA, Circular Genomics is positioning itself as a leader in the field of psychiatric and neurological diagnostics, enabling healthcare professionals to better address complex mental health issues.

TARGAN is a bio-systems company dedicated to enhancing animal health and productivity in the poultry, livestock, and aquaculture sectors. It is developing an innovative vaccination system that aims to replace traditional mass spray methods with a more precise approach, ensuring that every newly hatched chick receives the appropriate vaccine. This technology not only aims to improve immunization rates but also enhances the natural immune response to diseases, leading to better overall flock health. By increasing vaccination accuracy and consistency, TARGAN's solution helps reduce reliance on antibiotics, contributing to cleaner and healthier livestock. The company's focus on improving animal well-being and operational efficiency positions it as a leader in the field of animal production.

Advanced Animal Diagnostics, Inc. focuses on the research, development, and commercialization of on-farm diagnostic tools aimed at the early detection of subclinical mastitis in dairy cows. Based in Durham, North Carolina, the company offers products such as the QScout Farm Lab, an analyzer system that identifies infections in dairy cows before symptoms manifest, and the QScout Milk Leukocyte Differential rapid test, which analyzes milk to detect and differentiate white blood cells indicative of mastitis. Additionally, Advanced Animal Diagnostics provides solutions like QuickSmear, a rapid differential slide that aids in animal research, and the SCC+ System for early mastitis detection. These diagnostic tools are designed to enhance animal health management, benefiting veterinarians and livestock producers by enabling timely detection of infections and supporting informed treatment decisions. Founded in 2001, the company aims to improve the overall health and productivity of production animals.

Silicon Ranch Corporation is a developer, owner, and operator of utility-scale solar power projects, headquartered in Nashville, Tennessee. Founded in 2010, the company focuses on creating cost-effective solar energy solutions for a diverse range of clients, including utilities, military facilities, and various industrial and commercial businesses. Silicon Ranch is committed to long-term ownership of its projects, ensuring ongoing support and performance accountability to its partners and the communities it serves. In addition to its solar installations, which include facilities in Georgia and Tennessee, the company also operates a regional energy-training center that provides training in solar installation, maintenance, and weatherization. This comprehensive approach not only promotes the adoption of renewable energy but also contributes to local economic development and job creation.

AN2 Therapeutics, Inc. is a biopharmaceutical company based in Menlo Park, California, founded in 2017. The company is dedicated to the research, development, and commercialization of innovative medicines aimed at addressing infectious diseases. AN2 Therapeutics is focused on developing epetraborole, a once-daily oral treatment for patients suffering from chronic non-tuberculous mycobacterial lung disease, which represents a significant unmet medical need. Additionally, the company has established a strategic partnership with Brii Biosciences to enhance its development efforts.

TARGAN is a bio-systems company dedicated to enhancing animal health and productivity in the poultry, livestock, and aquaculture sectors. It is developing an innovative vaccination system that aims to replace traditional mass spray methods with a more precise approach, ensuring that every newly hatched chick receives the appropriate vaccine. This technology not only aims to improve immunization rates but also enhances the natural immune response to diseases, leading to better overall flock health. By increasing vaccination accuracy and consistency, TARGAN's solution helps reduce reliance on antibiotics, contributing to cleaner and healthier livestock. The company's focus on improving animal well-being and operational efficiency positions it as a leader in the field of animal production.

PhaseBio is a clinical-stage biopharmaceutical company focused on developing innovative therapies for endocrine and metabolic disorders, as well as cardiovascular diseases. The company leverages its proprietary elastin-like polypeptides (ELPs) technology to enhance the stability, bioavailability, and efficacy of proteins and peptides. Its lead candidate, PB1023, is in a phase 2b clinical trial for managing hyperglycemia in type 2 diabetes, with potential applications in obesity. Additionally, PhaseBio is advancing Vasomera, a candidate in phase 1 trials aimed at treating pulmonary arterial hypertension and heart failure. The company is also exploring PB2452, a novel reversal agent for the antiplatelet drug ticagrelor, and PB1046 for pulmonary arterial hypertension. With a commitment to addressing unmet medical needs, PhaseBio is headquartered in Malvern, Pennsylvania.

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases with targets in heart, liver, and neurodegenerative indications. It was founded in 2014 and is based in Boston, Massachusetts.

NeuroTronik, spun out of medical technology incubator Synecor, is developing a medical device that could take the place of drugs currently used to heart failure. Read more about the company's technology,

Boragen Inc. is a biotechnology company based in Durham, North Carolina, founded in 2015. The company specializes in developing multi-functional small molecule boron solutions for applications in crop protection, animal health, and human health. Boragen's product pipeline includes BAG8, a boron-based multisite fungicide aimed at crop protection, and BN2266, a fungicide that targets mRNA processing. Additionally, the company is working on a dual-function nematicide-fungicide for root protection and endo-parasiticides designed to overcome resistance. Boragen's innovative synthetic chemistry platform focuses on creating next-generation fungicides that support sustainable farming by minimizing the risk of fungicide resistance and reducing chemical usage while ensuring efficacy and performance.

G1 Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative small molecule therapeutics for cancer treatment. The company is advancing several key drug candidates, including trilaciclib, an intravenous cyclin-dependent kinases (CDK) 4/6 inhibitor currently in Phase 1b/2 trials for extensive-stage small cell lung cancer (SCLC) and Phase 2 trials for first-line SCLC and metastatic triple-negative breast cancer. Additionally, G1 Therapeutics is developing lerociclib, an oral CDK4/6 inhibitor in Phase 1b/2a trials for breast cancer and Phase 1b trials for non-small cell lung cancer, as well as rintodestrant, an oral selective estrogen receptor degrader in Phase I/2 trials. The company partners with Quantum Leap Healthcare Collaborative to explore trilaciclib for neoadjuvant treatment of locally advanced breast cancer. Founded in 2008 and based in Research Triangle Park, North Carolina, G1 Therapeutics aims to address unmet needs in oncology through its novel therapeutic approaches.

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases with targets in heart, liver, and neurodegenerative indications. It was founded in 2014 and is based in Boston, Massachusetts.

splitsecnd is the only portable and effective portable plug-in vehicle connectivity device on the market. Designed to simply plug into the 12V lighter outlet in any car, splitsecnd can detect a crash, connect you to a live operator, send help to your location, and notify your emergency contact in an instant. Perfect for seniors, teens, and drivers of all ages, splitsecnd uses airbag sensor technology to activate the emergency response system on impact, calling for help even if you can’t respond; it can also be activated manually in the event of a 9-1-1 emergency or roadside breakdown. And with comprehensive trip analytics and GPS capabilities, splitsecnd lets you track routes, encourage good driving habits and even find your parked car. splitsecnd keeps up with you and your family on the road no matter where you are, what you drive, or what the situation. No cell phone required.

Restore Medical Solutions is a medical device company focusing on products and techniques that promote SSI reduction, safety, and productivity within healthcare. The company manufactures a sterilization tray system that reduces the risk of infection from contaminated medical instruments. Its modular sterilization tray systems reduce the potential risk of infection from contaminated instruments and enable surgical departments to improve the quality of care while reducing cost. Founded in 2012, Restore Medical Solutions is headquartered in Memphis, Tennessee.

MedCenterDisplay offers a multifunctional network that helps healthcare organizations connect with patients in a robust way. They focus on providing healthcare marketers with turn-key solutions backed by engaging, creative content. The company's digital signage systems allow healthcare organizations to reach each and every person who walks through the door. Developed and tested by physicians and medical staff, MedCenterDisplay is an advanced digital communication network specifically designed to meet the needs of healthcare facilities. Their multi-functional network immediately engages patients and their families while they are waiting to see their healthcare provider.

NuSirt Sciences, Inc. is a biotechnology company dedicated to developing innovative treatments for metabolic diseases related to over-nutrition, such as obesity and type 2 diabetes. The company has created a unique technology platform that combines natural compounds with pharmaceutical agents to activate sirtuin pathways, aiming to prevent and treat chronic conditions associated with aging. Its lead product, NS-0100, merges the natural compound leucine with a low dose of metformin, which is commonly used for managing early type 2 diabetes but often causes gastrointestinal side effects that limit patient tolerance. Currently, NuSirt is conducting Phase 2 clinical trials to determine the most effective dosage of NS-0100. The company has filed eleven patent applications, with two already issued, and has successfully completed several clinical and pre-clinical studies based on its proprietary technologies. Founded in 2007 and based in Nashville, Tennessee, NuSirt Sciences continues to focus on advancing solutions for chronic diseases, particularly those related to metabolic dysfunction.

Contego Medical, Inc. specializes in developing embolic protection devices aimed at treating cardiovascular and endovascular diseases. The company offers a range of innovative products, including angioplasty balloons and stent delivery catheters, which integrate embolic protection technology. This portfolio includes systems such as the Paladin Carotid PTA Balloon System, the Vanguard IEP Peripheral Balloon Angioplasty System, and the Excipio SV Thrombectomy Device, all designed to enhance patient outcomes and procedural efficiency during treatments for conditions like carotid artery disease, peripheral artery disease, and deep vein thrombosis. Founded in 2005 and headquartered in Raleigh, North Carolina, Contego Medical also maintains an office in Curitiba, Brazil, reflecting its commitment to addressing the needs of healthcare professionals in cardiovascular procedures.

G1 Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative small molecule therapeutics for cancer treatment. The company is advancing several key drug candidates, including trilaciclib, an intravenous cyclin-dependent kinases (CDK) 4/6 inhibitor currently in Phase 1b/2 trials for extensive-stage small cell lung cancer (SCLC) and Phase 2 trials for first-line SCLC and metastatic triple-negative breast cancer. Additionally, G1 Therapeutics is developing lerociclib, an oral CDK4/6 inhibitor in Phase 1b/2a trials for breast cancer and Phase 1b trials for non-small cell lung cancer, as well as rintodestrant, an oral selective estrogen receptor degrader in Phase I/2 trials. The company partners with Quantum Leap Healthcare Collaborative to explore trilaciclib for neoadjuvant treatment of locally advanced breast cancer. Founded in 2008 and based in Research Triangle Park, North Carolina, G1 Therapeutics aims to address unmet needs in oncology through its novel therapeutic approaches.

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases with targets in heart, liver, and neurodegenerative indications. It was founded in 2014 and is based in Boston, Massachusetts.

Lineagen, Inc. is a genetics diagnostic company based in Salt Lake City, Utah, that specializes in genetic testing and clinical information services for neurodevelopmental disorders, particularly autism spectrum disorders (ASDs). Founded in 2002, Lineagen offers several key products, including FirstStepDx PLUS, a chromosomal microarray platform designed to identify genomic changes associated with autism, and NextStepDx PLUS, a genetic sequencing test that detects small genomic alterations. Additionally, the company provides M-CHAT.org, an online tool for developmental screening. Lineagen aims to improve outcomes for individuals affected by complex diseases through early diagnosis and intervention, leveraging extensive proprietary research and access to the Utah Population Database to enhance its understanding of genetic contributions to these conditions. As of August 2020, Lineagen operates as a subsidiary of Bionano Genomics, Inc.

Clearside Biomedical is a biopharmaceutical company focused on developing and delivering treatments for serious eye diseases, aiming to restore and preserve vision. Founded in 2011 and headquartered in Alpharetta, Georgia, the company employs a proprietary ocular microinjection platform that allows for targeted delivery of therapeutic agents to specific compartments of the eye, such as the retina and choroid. Among its products, XIPERE is a triamcinolone acetonide injectable suspension designed for treating macular edema linked to conditions like uveitis and diabetic macular edema. Additionally, the company's CLS-AX is being developed as an axitinib formulation for suprachoroidal injection. Clearside's innovative approach provides a non-surgical and repeatable method for administering therapies, which could significantly benefit patients with sight-threatening eye diseases.

MedCenterDisplay offers a multifunctional network that helps healthcare organizations connect with patients in a robust way. They focus on providing healthcare marketers with turn-key solutions backed by engaging, creative content. The company's digital signage systems allow healthcare organizations to reach each and every person who walks through the door. Developed and tested by physicians and medical staff, MedCenterDisplay is an advanced digital communication network specifically designed to meet the needs of healthcare facilities. Their multi-functional network immediately engages patients and their families while they are waiting to see their healthcare provider.

Castle Biosciences, Inc. is a commercial-stage biotechnology company focused on developing and commercializing diagnostic and prognostic tests for dermatological cancers. The company's lead product, DecisionDx-Melanoma, is a multi-gene expression profile test designed to identify stage I and II melanoma patients at high risk of metastasis by analyzing biological information from 31 genes in tumor tissue. In addition, Castle Biosciences offers the DecisionDx-UM test, which predicts metastasis risk in uveal melanoma patients, and is developing two late-stage products targeting cutaneous squamous cell carcinoma and suspicious pigmented lesions. The company's tests provide personalized, clinically actionable genomic information to assist physicians and patients in making informed treatment decisions. Founded in 2007 and headquartered in Friendswood, Texas, Castle Biosciences aims to significantly impact cancer diagnosis and management through its innovative diagnostic solutions.

InvisionHeart is a company focused on enhancing cardiac care through its innovative hardware and software system designed to capture and manage cardiac data. Originating from research conducted by physicians and engineers at Vanderbilt University, the technology addresses real-world clinical challenges faced by heart patients. InvisionHeart offers a mobile electrocardiograph system that allows a network of healthcare professionals, including physicians, nurses, and technicians, to securely access and annotate patient electrocardiogram tracings. The company's leadership, consisting of experienced professionals in both software and hardware development, along with a strong clinical advisory team, is dedicated to improving the care of heart patients in diverse environments.

Founded in 2011 and based in Nashville, TN, Diagnovus’s mission is to improve the health of patients and quality of treatment decisions through truly innovative molecular diagnostics by better informing physicians, patients and families that face these difficult disease prospects. Their core principles are defined by a passion to serve and dedication to create evidence-based molecular diagnostic products. By employing these values and principles, they believe they will make a meaningful contribution to improving outcomes for patients, help physicians to provide more effective care and contribute to a more efficient use of health care resources.

G1 Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative small molecule therapeutics for cancer treatment. The company is advancing several key drug candidates, including trilaciclib, an intravenous cyclin-dependent kinases (CDK) 4/6 inhibitor currently in Phase 1b/2 trials for extensive-stage small cell lung cancer (SCLC) and Phase 2 trials for first-line SCLC and metastatic triple-negative breast cancer. Additionally, G1 Therapeutics is developing lerociclib, an oral CDK4/6 inhibitor in Phase 1b/2a trials for breast cancer and Phase 1b trials for non-small cell lung cancer, as well as rintodestrant, an oral selective estrogen receptor degrader in Phase I/2 trials. The company partners with Quantum Leap Healthcare Collaborative to explore trilaciclib for neoadjuvant treatment of locally advanced breast cancer. Founded in 2008 and based in Research Triangle Park, North Carolina, G1 Therapeutics aims to address unmet needs in oncology through its novel therapeutic approaches.

Founded in 2011 and based in Nashville, TN, Diagnovus’s mission is to improve the health of patients and quality of treatment decisions through truly innovative molecular diagnostics by better informing physicians, patients and families that face these difficult disease prospects. Their core principles are defined by a passion to serve and dedication to create evidence-based molecular diagnostic products. By employing these values and principles, they believe they will make a meaningful contribution to improving outcomes for patients, help physicians to provide more effective care and contribute to a more efficient use of health care resources.

ABT Molecular Imaging is a medical imaging company that specializes in the design, manufacture, and marketing of biomarker generator systems for positron emission tomography (PET). Headquartered in Knoxville, Tennessee, the company offers the BG-75 Biomarker Generator, which produces unit doses of molecular imaging drugs on demand, facilitating immediate use at the point of care. The generator incorporates features such as quality control tests and detailed dose records to ensure reliability and compliance. Founded by Ron and Lynda Nutt in 2006, ABT aims to enhance the global expansion of PET imaging by providing innovative solutions for pharmaceutical companies. Its products are distributed through a comprehensive network of sales and service partners.

SwingPal, LLC is an online platform based in Franklin, Tennessee, that specializes in providing golf instruction through a digital interface. Founded in 2010, it connects golfers with professional instructors via a user-friendly system accessible on both the web and mobile devices. Users can record their golf swings using their smartphones and upload these videos to their SwingPal accounts. The platform then offers detailed and annotated analyses, combining video feedback with audio commentary from golf professionals. This service aims to help users refine their skills and improve their overall game.

Streamweaver is a software company located in Nashville, Tenn. The company's first product is a multi-angle mobile video app that automatically connects people to record together and then generates split-screen video.

Founded in 2011 and based in Nashville, TN, Diagnovus’s mission is to improve the health of patients and quality of treatment decisions through truly innovative molecular diagnostics by better informing physicians, patients and families that face these difficult disease prospects. Their core principles are defined by a passion to serve and dedication to create evidence-based molecular diagnostic products. By employing these values and principles, they believe they will make a meaningful contribution to improving outcomes for patients, help physicians to provide more effective care and contribute to a more efficient use of health care resources.

Pathfinder Technologies (formerly Pathfinder Therapeutics, Inc.), a medical device company, engages in the design, development, and manufacture of solutions in the field of navigated abdominal surgery. The company provides an integrated intra-operative image guidance system for open liver surgical procedure; and accessories, including IRED localization probes, navigated RF ablators, and navigated ultrasonic aspirators. Its system consists of a software architecture that allows the surgeon to display a 3D view of the liver. Its system is used in various open liver surgery applications, including hepatic resection, open ablation, open biopsy, living donor transplant, cyst removal, and tumor removal. Pathfinder Technologies was founded in 2004 and is based in Nashville, Tennessee.

Founded in 2011 and based in Nashville, TN, Diagnovus’s mission is to improve the health of patients and quality of treatment decisions through truly innovative molecular diagnostics by better informing physicians, patients and families that face these difficult disease prospects. Their core principles are defined by a passion to serve and dedication to create evidence-based molecular diagnostic products. By employing these values and principles, they believe they will make a meaningful contribution to improving outcomes for patients, help physicians to provide more effective care and contribute to a more efficient use of health care resources.

American Hometown Media, Inc. is a digital media company based in Franklin, Tennessee, that specializes in connecting with American home cooks through its internet platform. Founded in 2011, the company continues the tradition of analog publishing by syndicating editorial content that celebrates hometown cooks to community newspapers, magazines, and various media outlets across the nation. Its offerings include Just A Pinch Recipes, a digital social network focused on recipes and coupons for home cooks, and Just A Pinch Syndicated Media, which delivers content related to home cooking and American culture to a wide audience. American Hometown Media leverages its roots in traditional media while embracing digital innovation, reaching approximately two million households weekly with its syndicated columns.

Pathfinder Technologies (formerly Pathfinder Therapeutics, Inc.), a medical device company, engages in the design, development, and manufacture of solutions in the field of navigated abdominal surgery. The company provides an integrated intra-operative image guidance system for open liver surgical procedure; and accessories, including IRED localization probes, navigated RF ablators, and navigated ultrasonic aspirators. Its system consists of a software architecture that allows the surgeon to display a 3D view of the liver. Its system is used in various open liver surgery applications, including hepatic resection, open ablation, open biopsy, living donor transplant, cyst removal, and tumor removal. Pathfinder Technologies was founded in 2004 and is based in Nashville, Tennessee.

SwingPal, LLC is an online platform based in Franklin, Tennessee, that specializes in providing golf instruction through a digital interface. Founded in 2010, it connects golfers with professional instructors via a user-friendly system accessible on both the web and mobile devices. Users can record their golf swings using their smartphones and upload these videos to their SwingPal accounts. The platform then offers detailed and annotated analyses, combining video feedback with audio commentary from golf professionals. This service aims to help users refine their skills and improve their overall game.

Streamweaver is a software company located in Nashville, Tenn. The company's first product is a multi-angle mobile video app that automatically connects people to record together and then generates split-screen video.

ABT Molecular Imaging is a medical imaging company that specializes in the design, manufacture, and marketing of biomarker generator systems for positron emission tomography (PET). Headquartered in Knoxville, Tennessee, the company offers the BG-75 Biomarker Generator, which produces unit doses of molecular imaging drugs on demand, facilitating immediate use at the point of care. The generator incorporates features such as quality control tests and detailed dose records to ensure reliability and compliance. Founded by Ron and Lynda Nutt in 2006, ABT aims to enhance the global expansion of PET imaging by providing innovative solutions for pharmaceutical companies. Its products are distributed through a comprehensive network of sales and service partners.

Streamweaver is a software company located in Nashville, Tenn. The company's first product is a multi-angle mobile video app that automatically connects people to record together and then generates split-screen video.

Founded in 2011 and based in Nashville, TN, Diagnovus’s mission is to improve the health of patients and quality of treatment decisions through truly innovative molecular diagnostics by better informing physicians, patients and families that face these difficult disease prospects. Their core principles are defined by a passion to serve and dedication to create evidence-based molecular diagnostic products. By employing these values and principles, they believe they will make a meaningful contribution to improving outcomes for patients, help physicians to provide more effective care and contribute to a more efficient use of health care resources.

Pathfinder Technologies (formerly Pathfinder Therapeutics, Inc.), a medical device company, engages in the design, development, and manufacture of solutions in the field of navigated abdominal surgery. The company provides an integrated intra-operative image guidance system for open liver surgical procedure; and accessories, including IRED localization probes, navigated RF ablators, and navigated ultrasonic aspirators. Its system consists of a software architecture that allows the surgeon to display a 3D view of the liver. Its system is used in various open liver surgery applications, including hepatic resection, open ablation, open biopsy, living donor transplant, cyst removal, and tumor removal. Pathfinder Technologies was founded in 2004 and is based in Nashville, Tennessee.

SwingPal, LLC is an online platform based in Franklin, Tennessee, that specializes in providing golf instruction through a digital interface. Founded in 2010, it connects golfers with professional instructors via a user-friendly system accessible on both the web and mobile devices. Users can record their golf swings using their smartphones and upload these videos to their SwingPal accounts. The platform then offers detailed and annotated analyses, combining video feedback with audio commentary from golf professionals. This service aims to help users refine their skills and improve their overall game.

NuSirt Sciences, Inc. is a biotechnology company dedicated to developing innovative treatments for metabolic diseases related to over-nutrition, such as obesity and type 2 diabetes. The company has created a unique technology platform that combines natural compounds with pharmaceutical agents to activate sirtuin pathways, aiming to prevent and treat chronic conditions associated with aging. Its lead product, NS-0100, merges the natural compound leucine with a low dose of metformin, which is commonly used for managing early type 2 diabetes but often causes gastrointestinal side effects that limit patient tolerance. Currently, NuSirt is conducting Phase 2 clinical trials to determine the most effective dosage of NS-0100. The company has filed eleven patent applications, with two already issued, and has successfully completed several clinical and pre-clinical studies based on its proprietary technologies. Founded in 2007 and based in Nashville, Tennessee, NuSirt Sciences continues to focus on advancing solutions for chronic diseases, particularly those related to metabolic dysfunction.

MedCenterDisplay offers a multifunctional network that helps healthcare organizations connect with patients in a robust way. They focus on providing healthcare marketers with turn-key solutions backed by engaging, creative content. The company's digital signage systems allow healthcare organizations to reach each and every person who walks through the door. Developed and tested by physicians and medical staff, MedCenterDisplay is an advanced digital communication network specifically designed to meet the needs of healthcare facilities. Their multi-functional network immediately engages patients and their families while they are waiting to see their healthcare provider.

Diabetes Care Group, Inc. is a provider of specialized clinical care services for individuals with diabetes, based in Jackson, Mississippi. Founded in 1986, the company focuses on delivering an interdisciplinary model that integrates medical management, patient education, and behavioral modification. Their services include personalized counseling, diet and nutrition guidance, blood glucose monitoring, and point-of-care laboratory testing, all aimed at enhancing patient self-management and clinical outcomes. With a commitment to reducing the overall medical and social costs associated with diabetes, Diabetes Care Group employs a team of experienced professionals, including board-certified physicians, registered nurse educators, and registered dieticians. This integrated approach is backed by over ten years of research and clinical experience, demonstrating significant improvements in health outcomes for patients facing the challenges of diabetes.

ONFocus Healthcare, originally established in 1985 as m21partners, transitioned in 2008 to focus on providing business execution software solutions specifically for the healthcare sector. The company specializes in enterprise performance management (EPM) software and support services designed to enhance the operational effectiveness of healthcare organizations. Their flagship product, onFocus epm™, facilitates improved patient care by enabling hospitals to track and manage plans, metrics, and resources more efficiently. By offering both software and advisory services, ONFocus Healthcare aims to boost the execution success and performance of healthcare providers by at least 20%, ultimately ensuring patients receive better, faster, and more cost-effective care.

Pathfinder Technologies (formerly Pathfinder Therapeutics, Inc.), a medical device company, engages in the design, development, and manufacture of solutions in the field of navigated abdominal surgery. The company provides an integrated intra-operative image guidance system for open liver surgical procedure; and accessories, including IRED localization probes, navigated RF ablators, and navigated ultrasonic aspirators. Its system consists of a software architecture that allows the surgeon to display a 3D view of the liver. Its system is used in various open liver surgery applications, including hepatic resection, open ablation, open biopsy, living donor transplant, cyst removal, and tumor removal. Pathfinder Technologies was founded in 2004 and is based in Nashville, Tennessee.

Founded in 2011 and based in Nashville, TN, Diagnovus’s mission is to improve the health of patients and quality of treatment decisions through truly innovative molecular diagnostics by better informing physicians, patients and families that face these difficult disease prospects. Their core principles are defined by a passion to serve and dedication to create evidence-based molecular diagnostic products. By employing these values and principles, they believe they will make a meaningful contribution to improving outcomes for patients, help physicians to provide more effective care and contribute to a more efficient use of health care resources.

Industrial Ceramic Solutions, LLC, based in Oak Ridge, Tennessee, specializes in the development and manufacture of air pollution control equipment, particularly for industrial and diesel exhaust filter applications. Founded in 1997 by Richard Nixdorf, who possesses over 40 years of experience in advanced materials, the company initially focused on creating a microwave regenerated diesel particulate filter using patented silicon carbide fibers. These fibers were designed to rapidly convert microwave energy into thermal energy, facilitating the high-temperature cleaning required for diesel engine exhaust filters mandated by the US Clean Air Act. Although the microwave regeneration approach proved impractical, the company’s diesel particulate filter cartridge garnered significant attention from international automotive suppliers. In 2007, a Fortune 100 company licensed the technology, but this agreement ended in 2008 due to a downturn in the diesel engine market. Industrial Ceramic Solutions continues to innovate in air and gas filtration technologies, offering a range of products designed to control and eliminate pollutants effectively.

Panopto helps businesses and universities create searchable video libraries of their institutional knowledge. Since 2007, the company has been a pioneer in video capture software, video content management systems, and inside-video search technology. Today, Panopto’s video platform is the largest repository of expert learning videos in the world. Headquartered in Seattle with offices in Pittsburgh, London, Hong Kong, Beijing, and Sydney, Panopto has received industry recognition for its innovation, rapid growth, and company culture.

ONFocus Healthcare, originally established in 1985 as m21partners, transitioned in 2008 to focus on providing business execution software solutions specifically for the healthcare sector. The company specializes in enterprise performance management (EPM) software and support services designed to enhance the operational effectiveness of healthcare organizations. Their flagship product, onFocus epm™, facilitates improved patient care by enabling hospitals to track and manage plans, metrics, and resources more efficiently. By offering both software and advisory services, ONFocus Healthcare aims to boost the execution success and performance of healthcare providers by at least 20%, ultimately ensuring patients receive better, faster, and more cost-effective care.